Jeena Sikho Lifecare Q3FY26 Investor Presentation: Revenue Up 92% YoY
Jeena Sikho Lifecare's Q3 FY26 investor presentation shows a 92% YoY revenue increase to ₹221.66 crore. EBITDA margins remained at 45%. The company plans to launch a Health Card and has over 475 beds under development. Patient volumes and product sales are driving growth.
The announcement provides detailed financial results and strategic outlook, which are material information for investors and significantly impact their investment decisions.
The company reported strong year-over-year revenue growth, improved EBITDA margins, and outlined positive future growth strategies, including capacity expansion and new product initiatives.
Jeena Sikho Lifecare Limited has released its investor presentation for Q3 FY 2025-26, detailing its financial performance and strategic initiatives. The company reported a significant year-over-year revenue growth of 92% in Q3, reaching ₹221.66 crore. This performance was driven by a 17% quarter-over-quarter increase and sustained volume expansion across its business segments, particularly in Ayurveda healthcare services and products.
Profitability remained strong, with EBITDA margins steady at 45% in Q3. For the nine-month period of FY26 (9MFY26), EBITDA margins improved to 46% compared to 29% in FY25, indicating enhanced scalability and efficiency. The services segment saw robust patient volumes in both IPD and OPD formats, with notable traction in Day Care centers and Video-Call consultations.
The company is set to launch the Jeena Sikho Health Card to offer enhanced customer value. Furthermore, the Ayurveda healthcare products segment continues to grow, supported by new product launches and demand for its existing portfolio. Looking ahead, Jeena Sikho Lifecare Limited plans capacity expansion with over 475 beds under development and is exploring international expansion.
The presentation also provided a detailed overview of the company's business model, market approach, operational reach, and financial milestones. Key financial highlights for Q3FY26 included Revenue from Operations at ₹22,166 lakhs, EBITDA at ₹10,080 lakhs, and Profit After Taxes at ₹6,673 lakhs. Basic Earnings Per Share (EPS) stood at ₹5.37 for the quarter.
What to do with a filing like this
Jeena Sikho Lifecare Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jeena Sikho Lifecare Limited. Read the original for the full detail.